This 24-year-old target demonstrates promise across multiple chronic diseases and has been prioritized by two AI-driven longevity companies. The quality of the chemistry will decide the winner.
Thanks Alex for this insightful analysis of the Inflammasome and its relevance to human biology - especially now the potential of NLRP3 ... I remember highlighting this many years ago when I was part of Pharma - that was not taken seriously. Glad that it is now getting its day in the sun! Best Wishes to you and InSilico ... Ravi Kiron
Thanks Alex for this insightful analysis of the Inflammasome and its relevance to human biology - especially now the potential of NLRP3 ... I remember highlighting this many years ago when I was part of Pharma - that was not taken seriously. Glad that it is now getting its day in the sun! Best Wishes to you and InSilico ... Ravi Kiron
Thank you, Ravi! It looks like this is one of the best molecules we have ever designed.